Allergy Shots for Dog Allergy: Component Testing Before You Commit
Allergy shots for dog allergy are subcutaneous immunotherapy (SCIT) given to HUMANS sensitized to dog dander — not veterinary products injected into the dog. Cytopoint, Apoquel, and veterinary ASIT are for the dog. The most important step before dog SCIT is component testing: Can f 1 vs Can f 5 vs Can f 3 — because 16.5% of dog-sensitized adults are Can f 5-monosensitized and can skip immunotherapy by adopting a female dog.
7 peer-reviewed sources
Allergy shots for dog allergy treat HUMANS sensitized to dog dander via SCIT. Before starting, component-resolved testing (Can f 1 vs Can f 5) determines whether you even need shots. 16.5% of dog-sensitized adults are Can f 5-monosensitized and can skip SCIT by adopting a female or neutered dog.
The essentials
Allergy shots for dog allergy are subcutaneous immunotherapy (SCIT) given to HUMANS sensitized to dog dander — not veterinary products injected into the dog. Cytopoint (Zoetis lokivetmab, anti-IL-31 monoclonal antibody given monthly to the dog for canine atopic dermatitis), Apoquel (Zoetis oclacitinib, oral JAK inhibitor for the dog), and veterinary allergen-specific immunotherapy (vet ASIT injected into the dog) are products for the dog itself, not for you. For canine atopic dermatitis in your dog, see a veterinarian. For YOUR dog allergy, this is the right page. This page covers human immunotherapy for dog-allergen sensitization.
The most important framing for dog allergy immunotherapy is component-resolved diagnosis FIRST. Dog allergy is not one sensitization — it is potentially sensitization to any combination of seven co-dominant dog allergens: Can f 1 (lipocalin, saliva/dander, 42–75% sensitization), Can f 2 (lipocalin, lung, ~25%), Can f 3 (serum albumin, ~67 kDa, 75–90% identity with other mammalian albumins), Can f 4 (odorant-binding protein), Can f 5 (28 kDa prostatic kallikrein, intact males only), Can f 6 (lipocalin, 67% identity with cat Fel d 4), Can f 7 (>60% similarity with dust-mite NPC2 proteins). Three clinical categories drive three different treatment decisions:
Can f 1-dominant (broadly dog-allergic): SCIT or SLIT may be considered, with acknowledgment that dog SCIT evidence is 'poor and conflicting' per Smith DM et al. (Ann Allergy Asthma Immunol 2016;116:188–193). Dog extracts are not FDA-standardized — unlike cat-hair and cat-pelt (the only FDA-standardized mammalian extracts in the US at 10,000 BAU/mL, Greer license #308), dog extracts are PNU-based or w/v with significant lot-to-lot variability.
Can f 5-monosensitized: Approximately 16.5% of dog-sensitized adults are sensitized only to Can f 5 (Özuygur Ermis SS et al., Allergy 2023;53:88–104, West Sweden Asthma Study). Can f 5 is produced exclusively in the prostate gland of intact male dogs — absent in female dogs and neutered males (Mattsson L et al., JACI 2009). Schoos AMM et al. (JACI Pract 2020;8:1592–1597) confirmed in a randomized DBPC challenge that all 7 Can f 5-monosensitized children showed no reaction to female-dog extract. These patients can adopt a female or neutered dog of any breed and skip immunotherapy entirely.
Can f 3-dominant: Can f 3 is a serum albumin sharing 75–90% sequence identity with other mammalian albumins. Dominant sensitization to Can f 3 often reflects cross-reactive sensitization from another mammal as the primary allergen (e.g., beef, pork, horse, cat). In this case, dog SCIT may be less effective than addressing the primary mammalian allergen.
The hypoallergenic-breed myth: Vredegoor JK et al. (JACI 2012;130[4]:904–9) measured Can f 1 in 196 dogs and found hypoallergenic breeds had HIGHER Can f 1 (geometric mean 2.26 µg/g vs 0.77 µg/g; P<0.001). Nicholas CE et al. (Am J Rhinol Allergy 2011) found detectable Can f 1 in 94% of 173 homes regardless of breed. No breed is genuinely safe for broadly dog-allergic patients. Curex offers at-home IgE component testing with board-certified allergist review for Can f 1, Can f 2, Can f 3, Can f 5, and Can f 6 — the diagnostically relevant dog allergens that drive three different treatment decisions: broad SCIT/SLIT, female-dog adoption for Can f 5-monosensitized patients (16.5% per Ozuygur Ermis 2023), or redirected immunotherapy targeting a primary non-dog mammalian sensitization. For Can f 1-dominant patients who do elect immunotherapy, Curex delivers that SCIT as an at-home allergy shot kit: a personalized serum sterile-compounded to USP <797>, self-administered as one weekly shot at home for $129/month, with the first dose and every dose change supervised live over Zoom by the prescribing allergist and a prescribed epinephrine auto-injector confirmed on hand — making safe at-home maintenance possible for eligible patients.
How allergy shots retrain your immune system
Dog allergy shots follow the same subcutaneous immunotherapy mechanism as other aeroallergen SCIT: repeated controlled allergen exposure shifting the IgE response toward IgG4 blocking antibodies and T-regulatory cell tolerance. The challenge is that dog's multi-allergen profile and non-standardized extracts make it harder to deliver a consistent therapeutic dose than cat or grass SCIT.
Component-Resolved Diagnosis (Step Zero)
Can f 1 vs Can f 5 vs Can f 3 testing determines the correct treatment path before any shots are considered. Can f 5-monosensitized patients (16.5% of dog-sensitized adults) should be identified before starting SCIT — they have a non-immunotherapy option.
Build-Up Phase (~26 weekly visits)
For Can f 1-dominant patients electing SCIT: weekly escalating injections with mandatory 30-minute post-injection observation at every visit per Cox 2011 PP3.
Maintenance Phase (3–5 years, every 2–4 weeks)
Every-2-to-4-week maintenance injections. No FDA-standardized reference dose exists for dog extract — unlike cat, the therapeutic dose target is based on general SCIT principles rather than Fel d 1-equivalent standardization.
12-Month Reassessment
Given the weak evidence base, a formal clinical reassessment at 12 months of maintenance is essential. If no meaningful improvement is documented, continuing the full course has limited evidence basis.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Treatment timeline — phase by phase
Dog SCIT follows the same three-phase structure as all SCIT. Year 1 requires approximately 39 in-clinic visits; Years 2–5 require 14–20 visits/year.
Weekly escalating injections during the build-up, each followed by a 30-minute observation. Conventionally in-clinic; with Curex the build-up is self-administered at home as one weekly shot, with the first dose and every dose change supervised live over Zoom by the prescribing allergist and a prescribed epinephrine auto-injector confirmed on hand.
Year 1: ~39 visits. Years 2–5: ~14–20 visits/year. Total: approximately 95–119 clinic visits.
Post-treatment benefit for dog SCIT is poorly characterized given the weak evidence base. Any residual benefit is extrapolated from general SCIT principles.
Efficacy by allergen — what the data shows
Dog SCIT evidence is genuinely weak. The component-resolved diagnostic workup may reveal that a significant subset of patients (Can f 5-monosensitized, 16.5%) have a superior non-pharmacological option — which makes the per-patient diagnostic step more valuable than committing to SCIT without it.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youTreatment options side by side
Dog-allergic patients have three distinct paths depending on component testing. The component test is the key clinical decision tool — not starting SCIT without it.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
At-Home Dog SCIT (Curex; Can f 1-dominant patients) | |||||
SLIT Drops (dog; needle-free modality) | |||||
Female/Neutered Dog Adoption (Can f 5-mono only) |
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
Curex's at-home allergy shot kit delivers personalized SCIT immunotherapy prescribed and overseen by a board-certified allergist at $129/month — the serum is sterile-compounded to USP <797> and customized to the patient's Can f component profile rather than the one-size-fits-all PNU-based dog extracts used in conventional SCIT, you self-administer one weekly shot at home, and your first dose and every dose change are supervised live over Zoom with a prescribed epinephrine auto-injector confirmed on hand.
See if at-home shots are right for youSide effects — what to watch for
Dog SCIT carries the same safety profile as all SCIT allergens. Systemic reactions are rare but require mandatory 30-minute at-home observation.
Insurance coverage — what to expect
Conventional in-clinic dog SCIT is covered by major commercial insurers when standard medical necessity criteria are met; Curex's at-home allergy shot kit is a $129/month cash-pay program (HSA/FSA eligible) with no copays. For full details, see /allergy-shots/cost/does-insurance-cover-allergy-shots.
Skip the insurance hassle — Curex is $129/mo flat, no insurance needed.
Start free assessmentFrequently asked questions
Should I test Can f 5 before starting dog allergy shots?
Yes — strongly recommended. Can f 5 is a prostatic kallikrein produced only in the prostate gland of intact male dogs (Mattsson L et al., JACI 2009). If your only positive IgE is to Can f 5 — approximately 16.5% of dog-sensitized adults per Özuygur Ermis SS et al. (Allergy 2023;53:88–104) — you can adopt a female or neutered dog of any breed and avoid immunotherapy entirely. Schoos AMM et al. (JACI Pract 2020;8:1592–1597) confirmed this in a randomized DBPC challenge: all 7 Can f 5-monosensitized children showed zero reaction to female-dog extract. A component IgE panel costing approximately $50–150 may replace years of weekly shots for one in six dog-sensitized patients.
Why do hypoallergenic dog breeds not solve dog allergy?
Hypoallergenic dog breeds do not produce significantly less Can f 1, the primary dog allergen. Vredegoor JK et al. (JACI 2012;130[4]:904–9) measured Can f 1 in 196 dogs and found hypoallergenic breeds had HIGHER Can f 1 (geometric mean 2.26 µg/g vs 0.77 µg/g for non-hypoallergenic breeds; P<0.001). Nicholas CE et al. (Am J Rhinol Allergy 2011) found no breed effect on Can f 1 levels across 173 homes; 94% had detectable Can f 1. The narrow exception: Can f 5-monosensitized patients can safely adopt female or neutered dogs of any breed, because Can f 5 is absent in those animals. Lockey RF (JACI 2012 editorial) called this 'the myth of hypoallergenic dogs (and cats)' based on this same evidence.
What is the Can f 3 sensitization and why does it change treatment?
Can f 3 is a ~67 kDa serum albumin that shares 75–90% sequence identity with serum albumins from other mammals — including cat, horse, cow, and pork. A patient with dominant IgE reactivity to Can f 3 often has primary sensitization to another mammalian albumin and cross-reactive dog sensitivity secondarily. In this case, dog SCIT targeting Can f 3 may be less effective than treating the actual primary allergen — for example, a patient sensitized via beef albumin (Bos d 6) with cross-reactivity to Can f 3. Component testing revealing Can f 3 dominance should prompt your allergist to investigate whether the primary allergen source is dog or another mammal.
Is dog allergy immunotherapy evidence as strong as cat allergy immunotherapy?
No — there is a substantial evidence gap. Cat-hair and cat-pelt are the only FDA-standardized mammalian extracts in the US (10,000 BAU/mL, Greer license #308), and cat SCIT has two rigorous DBPC RCTs showing ~72% symptom reduction (Varney 1997 Clin Exp Allergy) and significant improvement vs placebo (Alvarez-Cuesta 1994 JACI). Dog SCIT uses non-standardized PNU-based or w/v extracts with significant lot-to-lot variability. Smith DM and Coop CA (Ann Allergy Asthma Immunol 2016;116:188–193) reviewed 17 dog SCIT trials and rated evidence as 'poor and conflicting, attributed to poor-quality extracts and the inherent complex allergenic profile of dogs that remains without a clearly dominant allergen.' Patients and allergists should discuss this asymmetry honestly before committing to dog SCIT.
How long does the component test take before starting dog shots?
A component-resolved IgE blood test — measuring specific IgE to Can f 1, Can f 2, Can f 3, Can f 5, and Can f 6 — can be ordered at the initial allergist consultation. Results are typically available within 1–2 weeks. The test is a standard serum IgE panel (ImmunoCAP or equivalent). The allergist interprets component results in the context of your clinical history — specifically, which dog exposures correlate with symptoms and whether the sensitization pattern suggests true dog allergy or cross-reactive mammalian allergen sensitization. This 1-2-week diagnostic step is far shorter than the years of SCIT it can help you avoid if you are Can f 5-monosensitized.
Related Articles
Cat Allergy Shot for Humans | Curex SCIT Guide
This page covers cat allergy shots FOR HUMANS — SCIT with FDA-standardized Fel d 1 extract (10,000 BAU/mL). Not Cytopoint. Not Apoquel. ~72% symptom reduction in RCTs.
Read moreAllergy Shots for Cat Allergy | Full SCIT Guide | Curex
Allergy shots for cat allergies reduce symptoms 60-72% at the 15 mcg Fel d 1 maintenance dose. Cat SCIT efficacy, dosing, and alternatives.
Read moreAllergy Shots for Pet Dander | Curex Species Guide
Allergy shots for pet dander treat HUMANS sensitized to cat, dog, horse, or small-mammal allergens. Cat has FDA-standardized extract; dog evidence is 'poor and conflicting.'
Read moreTypes of Allergy Injections: Full Guide | Curex
Types of allergy injections include SCIT (immunotherapy), biologics like Xolair and Dupixent, depot steroids, and epinephrine. Only SCIT modifies the underlying disease.
Read moreAllergy Injection: One Visit Explained | Curex
An allergy injection is one step in a 3-to-5-year SCIT course. Learn pre-injection screening, technique, the 30-min observation, and why singular search intent often finds depot steroids instead.
Read moreAllergy Shots for Dog Allergies | Curex Human SCIT Guide
Allergy shots for dog allergies treat HUMANS — not dogs. Dog SCIT evidence is 'poor and conflicting' (Smith 2016). 16.5% of dog-sensitized adults can skip shots entirely.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.